Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 423

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

The safety and efficacy of sublingual and oral immunotherapy for milk allergy

Open access
Keet, Corinne A., Frischmeyer-Guerrerio, Pamela A., Thyagarajan, Ananth, Schroeder, John T., Hamilton, Robert G., Boden, Stephen, Steele, Pamela, Driggers, Sarah, Burks, A. Wesley, Wood, Robert A.·2012·Journal of Allergy and Clinical Immunology

Abstract

Background Oral immunotherapy (OIT) and sublingual immunotherapy (SLIT) are potential therapies for food allergy, but the optimal method of administration, mechanism of action, and duration of response remain unknown. Objective We sought to explore the safety and efficacy of OIT and SLIT for the treatment of cow’s milk (CM) allergy. Methods We randomized children with CM allergy to SLIT alone or SLIT followed by OIT. After screening double-blind, placebo-controlled food challenges and initial SLIT escalation, subjects either continued SLIT escalation to 7 mg daily or began OIT to either 1000 mg (the OITB group) or 2000 mg (the OITA group) of milk protein. They were challenged with 8 g of milk protein after 12 and 60 weeks of maintenance. If they passed the 60-week challenge, therapy was withdrawn, with challenges repeated 1 and 6 weeks later. Mechanistic correlates included end point titration skin prick testing and measurement of CM-specific IgE and IgG4 levels, basophil histamine release, constitutive CD63 expression, CD203c expression, and intracellular spleen tyrosine kinase levels. Results Thirty subjects with CM allergy aged 6 to 17 years were enrolled. After therapy, 1 of 10 subjects in the SLIT group, 6 of 10 subjects in the SLIT/OITB group, and 8 of 10 subjects in the OITA group passed the 8-g challenge (P = .002, SLIT vs OIT). After avoidance, 6 of 15 subjects (3 of 6 subjects in the OITB group and 3 of 8 subjects in the OITA group) regained reactivity, 2 after only 1 week. Although the overall reaction rate was similar, systemic reactions were more common during OIT than during SLIT. By the end of therapy, titrated CM skin prick test results and CD63 and CD203c expression decreased and CM-specific IgG4 levels increased in all groups, whereas CM-specific IgE and spontaneous histamine release values decreased in only the OIT group. Conclusion OIT was more efficacious for desensitization to CM than SLIT alone but was accompanied by more systemic side effects. Clinical desensitization was lost in some cases within 1 week off therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2011.10.023

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 423

Metadata

Authors
Keet, C. A., Frischmeyer-Guerrerio, P. A., Thyagarajan, A., Schroeder, J. T., Hamilton, R. G., Boden, S., Steele, P., Driggers, S., Burks, A. W., & Wood, R. A.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2012-02
Volume
129
Issue
2
Pages
448-455.e5
ISSN
0091-6749 (ISSN-L)
OpenAlex
W2022764839
Cited by
423
References
35
FWCI
25.92
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The safety and efficacy of sublingual and oral immunotherapy for milk allergy. https://app.cochat.ai/papers/10.1016/j.jaci.2011.10.023
The paper
Keet, C. A., Frischmeyer-Guerrerio, P. A., Thyagarajan, A., Schroeder, J. T., Hamilton, R. G., Boden, S., Steele, P., Driggers, S., Burks, A. W., & Wood, R. A. (2012). The safety and efficacy of sublingual and oral immunotherapy for milk allergy. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2011.10.023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.